$MDHI; Gross profit margins have improved from 41% in
$MDHI; Gross profit margins have improved from 41% in quarter’s end on March 31, 2013 to 79% in quarter’s end on March 31, 2014. Gross profit for quarter’s end on March 31, 2014 increased to $194,958 from the year earlier at $74,061. Revenues for the three months ended March 31, 2014 were $246,903, an increase of 38% over the $179,110 recorded for the corresponding period in 2013.
Nine-month figures also show year over year improvement with Medical Alarm Concepts Holding, Inc. reporting revenues of $768,494 for the nine months ended March 31, 2014 or a 65% improvement over the $464,475 recorded for the corresponding period ended March 31, 2013
http://www.youtube.com/watch?v=d1D9PYxHpEo
MDHI Medical Alarm Concepts Holding, Inc. Research DD Guide
Stock Quote
http://www.otcmarkets.com/stock/MDHI/quote
Stock Chart
http://www.otcmarkets.com/stock/MDHI/chart
Company Info
http://www.otcmarkets.com/stock/MDHI/company-info
Recent News
http://www.otcmarkets.com/stock/MDHI/news
Financials
http://www.otcmarkets.com/stock/MDHI/financials
Filings and Disclosure
http://www.otcmarkets.com/stock/MDHI/filings
Short Sales
http://www.otcmarkets.com/stock/MDHI/short-sales
Insider Disclosure
http://www.otcmarkets.com/stock/MDHI/insider-transactions
Research Reports
http://www.otcmarkets.com/stock/MDHI/research
Summary
http://finance.yahoo.com/q?s=MDHI
Historical Prices
http://finance.yahoo.com/q/hp?s=MDHI+Historical+Prices
Interactive Chart
http://finance.yahoo.com/echarts?s=MDHI
Basic Chart
http://finance.yahoo.com/q/bc?s=MDHI+Basic+Chart
Basic Tech. Analysis
http://finance.yahoo.com/q/ta?s=MDHI+Basic+Tech.+Analysis
Headlines
http://finance.yahoo.com/q/h?s=MDHI+Headlines
Press Releases
http://finance.yahoo.com/q/p?s=MDHI+Press+Releases
Company Profile
http://finance.yahoo.com/q/pr?s=MDHI+Profile
Key Statistics
http://finance.yahoo.com/q/ks?s=MDHI+Key+Statistics
Industry
http://finance.yahoo.com/q/in?s=MDHI+Industry
Major Holders
http://finance.yahoo.com/q/mh?s=MDHI+Major+Holders
Insider Transactions
http://finance.yahoo.com/q/it?s=MDHI+Insider+Transactions
Insider Roster
http://finance.yahoo.com/q/ir?s=MDHI+Insider+Roster
Income Statement
http://finance.yahoo.com/q/is?s=MDHI
Balance Sheet
http://finance.yahoo.com/q/bs?s=MDHI
Cash Flow
http://finance.yahoo.com/q/cf?s=MDHI+Cash+Flow&annual
Nasdaq
http://www.nasdaq.com/symbol/MDHI
Market Watch
http://www.marketwatch.com/investing/stock/MDHI
Bloomberg
http://www.bloomberg.com/quote/MDHI:US
Morningstar
http://quotes.morningstar.com/stock/s?t=MDHI
Bussinessweek
http://investing.businessweek.com/research/st...icker=MDHI
Barchart
http://www.barchart.com/quotes/stocks/MDHI
OTC Short Report
http://otcshortreport.com/index.php?index=MDHI
Investopedia
http://www.investopedia.com/markets/stocks/MDHI/?wa=0
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Preserving Our Natural Chompers Digging into the details of endodontic care, you realize how it's the unsung hero in the dental world. And let's face it, teeth don't get happier on their own when there's a problem on the inside. Dr. Christopher Joubert, a wiz on the endodontic front, spills the beans over at HelloNation about how essential these practices are in keeping...
Continue Reading
The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...
Continue Reading
Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...
Continue Reading
Revisiting a Prized Legacy: The 2027 Jeep Wrangler JL-2A Sometimes, what’s new is really just a nod to what’s old—and nowhere is this more so than with the 2027 Jeep Wrangler JL-2A. In the grand parade of automotive history, Jeep's latest creation is more than just a vehicle; it's a time machine that cruises on its historic lineage while strapping on all the modern...
Continue Reading
Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...
Continue Reading
Unraveling Ellison's Bold Decision There's nothing like a sudden shift from a tech titan to make Wall Street sit up and take notice. Today, we got the word that Larry Ellison, Oracle's big gun as Executive Chair and CTO, has pulled the plug on his plan to sell Oracle stock. No dice, no distance covered under that plan. And he's made it crystal clear—selling isn't on his...
Continue Reading
Investors Swim Against the Current With SMPL Picture this: You’re sipping your morning coffee, glancing through stocks, only to choke on your bagel when The Simply Good Foods Company (NASDAQ: SMPL) pops up with some less-than-palatable news. A class action is brewing, shouting out to investors who took the bait from October 24, 2024, to April 8, 2026. If you’re one of...
Continue Reading
The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...
Continue Reading
Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...
Continue Reading
Trouble Brews at D-Wave Quantum Smack in the middle of market chaos, D-Wave Quantum Inc. (NASDAQ: QBTS) seems to have hit a rather gnarly pothole. With disappointing revenue figures for Q2 of 2026—coming in at a measly $3.08 million, far below the expected range of $4.03 million to $4.08 million—investors have more than enough reasons to be irked. When the numbers...
Continue Reading
Top 5 Most Recently Viewed Articles
New Oriental Education & Technology Group Inc. Financial Results Overview New Oriental Education & Technology Group Inc. (NYSE: EDU) has recently unveiled its unaudited financial results for the second fiscal quarter ended November 30. This marks a significant period in the company's journey, highlighting an impressive rise in net revenues and overall financial...
Continue Reading
Continued Confidence Among CEOs and Investors in 2026 Growth Recent insights reveal that CEO and investor expectations for growth, mergers and acquisitions (M&A), and hiring are notably high. However, these aspirations come with caution, spurred by challenges related to global trade, geopolitical uncertainties, and rapid technological advancements. High Expectations for...
Continue Reading
The S&P 500 E-Mini futures market saw quite the ruckus back then. As traders scanned the weekly charts, smaller candlestick patterns hinted at a shift in momentum that got everyone on edge. They had their eyes glued to that 20-week exponential moving average (EMA)—a critical support level that bulls hoped would come through for them as they scrambled for a double-bottom...
Continue Reading
The Current Legal Landscape for Nutex Health Inc. Nutex Health Inc. is currently facing significant legal challenges that have sparked interest among its investors and market watchers. These challenges are crucial to understanding the company’s financial health and future prospects. Recently, a class action lawsuit was announced against the Company, raising concerns...
Continue Reading
Introduction to the Investigation Bragar Eagel & Squire, P.C., a respected law firm focused on investor rights, is currently investigating potential claims against BellRing Brands Inc. (BRBR). This inquiry aims to determine whether the company violated federal securities laws or engaged in unlawful business practices, impacting their shareholders. Investors who have...
Continue Reading